Form 4 for EW Edwards Lifesciences
Accepted 2024-02-21 00:00:00 ET · period of report 2024-02-21 · accession 0001225208-24-002654 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-02-21 | 2024-02-21 | EW | Chopra Daveen | CVP, TMTT | S - Sale+OE | $86.74 | -8,200 | 29.8K | -22% | -$711.3K |
| D | 2024-02-21 | 2024-02-21 | EW | Chopra Daveen | CVP, TMTT | M - OptEx | $59.26 | +7,000 | 30.9K | +29% | +$414.8K |
| D | 2024-02-21 | 2024-02-21 | EW | Chopra Daveen | CVP, TMTT | M - OptEx | $0.00 | -7,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-21 | S | D | 7,000 | $86.75 | 22,750 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $86.7455 to $86.7600. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2024-02-21 | S | D | 1,200 | $86.67 | 29,750 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $86.6600 to $86.6800. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2024-02-21 | M | A | 7,000 | $59.26 | 30,950 | D | — | — | |
| 4 | Derivative | Employee Stock Option (Right to Acquire) | 2024-02-21 | M | D | 7,000 | $0.00 | 0 | D | $59.26 · 2020-05-08 to 2026-05-07 | 7,000 Common Stock |